Drug Trial Radar · NCT06740526
Phase 2b Open-Label Repeat Kidney Biopsy Study
Last checked: Nov 20, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
56
Actual
Start
Dec 5, 2024
Primary completion
Dec 28, 2028
Study completion Dec 28, 2028
Sponsor
- Lead sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.Otsuka
- Sponsor type
- Industry
- First posted
- Dec 18, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Assess impact of sibeprenlimab on IgA deposition and other histological endpoints in kidney tissue at Week 52 relative to baseline
Conditions
- IgA Nephropathy
Interventions
SibeprenlimabDrug
Sibeprelimab SC (Period 1) Sibeprelimab SC (Period 2)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline in Glomerular IgA Deposition by Immunofluorescence in Kidney Tissue to Week 52Time frame: From Baseline to Week 52
Locations
19 sites in 5 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Stanford University Medical Center
Stanford, California
Colorado Kidney Care PC
Denver, Colorado
Massachusetts General Hospital (MGH) Harvard
Boston, Massachusetts
Dakota Dunes
Dakota Dunes, South Dakota
Prolato Clinical Research Center
Houston, Texas
Hospital Britanco de Buenos Aires
Buenos Aires, Argentina
Centro Medico Dra Laura Maffei- Investigacion Clinica Aplicada
Buenos Aires, Argentina
St. Paul's Hospital
Vancouver, British Columbia, Canada
Hamilton Centre for Kidney Research (HCKR)
Hamilton, Ontario, Canada
OTT Healthcare
Scarborough Village, Ontario, Canada
Kyushu University Hospital
Fukuoka, Japan
University of Miyazaki Hospital
Miyazaki, Japan
Juntendo University Hospital
Tokyo, Japan
Juntendo University - Urayasu Hospital
Urayasu, Chiba, Japan
Kobe University Hospital
Kobe, Hyōgo, Japan
Nara Medical University Hospital
Kashihara, Nara, Japan
Leicester General Hospital
Leicester, United Kingdom
King's College Hospital NHS Foundation Trust
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.